Topic: Psoriasis
DermWireTV: Sun's PsO Impact Survey, Dermatology.com Expansion, More
Series: DermWire TV | February 20, 2020
A Sun Pharma survey finds up to 44% of moderate-to-severe psoriasis patients often or sometimes feel humiliated by the appearance of plaques. Patients report effects on intimacy and relationships. Ortho Dermatologics adds telemedicine and new products to Dermatology.com. South Beach Symposium faculty shed light on therapeutic developments and the state of dermatology.
Updates in Pediatric Dermatology
Series: Maui Derm for Dermatologists 2020 | January 28, 2020
2019 was bookended by the release of new treatment guidelines for pediatric skin disorders. Sheila Fallon Friedlander, MD, gives an overview of these developments and other hot topics in pediatric dermatology.
The Latest in Psoriasis
Article | March 2020
Psoriasis Impacts QoL of Patients’ Partners
Article | March 2020
Review Confirms Apremilast Safety, Cost-Effectiveness
Article | March 2020
Biologic Therapy Appears Safe for Men Who Father Children
Article | March 2020
Tropical Disease Impacts Psoriasis in Patients on Biologics
VIDEO | January 28, 2020
Updates in Pediatric Dermatology
Meeting Coverage | Maui Derm for Dermatologists 2020
Maui, HI: January 25 - 29, 2020
Sheila Fallon-Friedlander, MD
VIDEO | January 28, 2020
Psoriasis Comorbidities
Meeting Coverage | Maui Derm for Dermatologists 2020
Maui, HI: January 25 - 29, 2020
Joel L. Cohen, MD, FAAD; and Joel M. Gelfand, MD, MSCE
VIDEO | January 27, 2020
The Science Driving Topicals Into the Future
Meeting Coverage | Maui Derm for Dermatologists 2020
Maui, HI: January 25 - 29, 2020
Neal Bhatia, MD, FAAD
VIDEO | January 27, 2020
Psoriasis 2020
Meeting Coverage | Maui Derm for Dermatologists 2020
Maui, HI: January 25 - 29, 2020
Bruce Strober, MD, PhD
Therapeutics Update | January 2020
New Products/New In My Practice: Rx
Send Us Your Questions
Practical Dermatology® is partnering with Adam Friedman, MD for a new video series. He'll answer your questions about skincare, skin health, and more.
Send Us Your Questions
